Pharmaceutical Sirolimus Rapamycin Anti-Rejection Rapamycin

• Customization: Available
• CAS No.: 53123-88-9
• Formula: C51h79no13
• Model NO.: QS-Rapamycin
• EINECS: 610-965-5
• Packaging Material: Metal
• Storage Method: Normal
• Shelf Life: >12 Months
• Nutrient Composition: Rapamycin
• Resource: Rapamycin
• The content of active substances: >99%
• MW: 914.172
• Mf: C51h79no13
• Purity: 99%
• Product Name: Rapamycin
• Name: Rapamycin Powder
• Appearance: White Powder
• Assay: 99%
• Test Method: HPLC
• Specific: COA
• Color: White
• Application: Pharmaceutical
• Grade: Pharmaceutical Grade
• Density: 1.182 g/cm3
• Melting Point: 183-185°c
• Boiling Point: 973.017ºC at 760 Mmhg
• Transport Package: Negotiable
• Specification: Negotiable
• Trademark: QS-Rapamycin
• Origin: Shaanxi Xi′an
• Production Capacity: 600kg/Month

Product Description

Pharmaceutical Sirolimus Rapamycin Anti-rejection Rapamycin

Product Description

Product Details

 

Product name	Rapamycin
Cas number	53123-88-9
Appearance	White powder
MF	C51H79NO13
MW	914.172

Rapamune is suitable for patients undergoing kidney transplantation to prevent organ rejection. It is recommended to use Rapamune preparations in combination with cyclosporine and corticosteroids

Application&Function

Rapamycin belongs to the macrolide antibiotic class, which has a similar structure to FK506, but has a very different immunosuppressive mechanism. FK506 inhibits the proliferation of T lymphocytes from G0 phase to G1 phase, while RAPA blocks signal transduction through different cytokine receptors, blocking the progression of T lymphocytes and other cells from G1 phase to S phase. Compared with FK506, RAPA can block calcium dependent and non calcium dependent signaling pathways of T lymphocytes and B lymphocytes.

Specification